Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8334301
5-Membered heterocyclic compound
granted -
US 8329900
Dipeptidyl peptidase inhibitors
granted -
US 8329691
Amide compounds and use of the same
granted -
US 8329687
Pyridooxazepine derivative and use thereof
granted -
US 8324383
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
granted -
US 8324201
Pyrazinooxazepine derivatives
granted -
US 8324395
Heterocyclic compound and use thereof
granted -
US 8318939
Kinase inhibitors
granted -
US 8318722
Pyrazinooxazepine derivatives
granted -
US 8318746
Nitrogen-containing five-membered heterocyclic compound
granted -
US 8318727
Polo-like kinase inhibitors
granted -
US 8314088
Pyrazinooxazepine derivatives
granted -
US 8309580
Heterocyclic compound
granted -
US 8304557
Fused heterocycle derivatives and use thereof
granted -
US 8299261
1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
granted -
US 8293901
MAPK/ERK kinase inhibitors
granted -
US 8288539
Dipeptidyl peptidase inhibitors
granted -
US 8288390
Benzofuran derivatives
granted -
US 8288536
Kinase inhibitors
granted -
US 8283353
Fused ring compound and use thereof
granted -
US 8278450
Kinase inhibitors
granted -
US 8273750
Organic compounds
granted -
US 8273741
Imidazo-pyridazinyl compounds and uses thereof
granted -
US 8273761
Tricyclic compound and medical use thereof
granted